Detalhe da pesquisa
1.
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.
Ann Oncol
; 31(5): 609-618, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201234
2.
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203).
ESMO Open
; 9(3): 102387, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401247
3.
Effect of iodothyronine hormone status on doxorubicin related cardiotoxicity.
Folia Morphol (Warsz)
; 72(4): 340-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24402757
4.
The coexistence of tuberculosis infection and lung cancer in patients treated in pulmonary department of Medical Academy in Lublin during last ten years (1990-2000).
Folia Histochem Cytobiol
; 39 Suppl 2: 73-4, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11820634
5.
Effect of tyrphostins on programmed cell death in colon adenocarcinoma cell line LS-180.
Folia Histochem Cytobiol
; 39 Suppl 2: 81-3, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11820638
6.
Expression of p21 and bcl-2 proteins and p53 mRNA in surgically resected preparations of non-small cell lung cancer (stage IIIA) after etoposide and cisplatin chemotherapy.
Folia Histochem Cytobiol
; 39 Suppl 2: 175-6, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11820594